Correlation between fine motor activity and striatal dopamine D2 receptor density in patients with schizophrenia and healthy controls

Psychiatry Research - Neuroimaging

Volumn 123, Issue 3, 2003, Pages 191-197

  Yang, Yen Kuang ^a   Chiu, Nan Tsing ^a   Chen, Chwen Cheng ^a,b   Chen, Mitchell ^a   Yeh, Tzung Lieh ^a   Lee, I Hui ^a  

^a NATIONAL CHENG KUNG UNIVERSITY HOSPITAL   (Taiwan)

^b PFIZER   (Taiwan)

Author keywords

Antipsychotics; Dopamine D2 receptor; Finger tapping test; Schizophrenia; Single photon emission computed tomography

Indexed keywords

DOPAMINE 2 RECEPTOR; N [(1 ETHYL 2 PYRROLIDINYL)METHYL] 3 IODO 6 METHOXYSALICYLAMIDE; NEUROLEPTIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORPUS STRIATUM; CORRELATION ANALYSIS; FEMALE; HEALTH STATUS; HUMAN; MALE; MENTAL PATIENT; MOTOR ACTIVITY; PRIORITY JOURNAL; PSYCHIATRIC TREATMENT; SCALE UP; SCHIZOPHRENIA; SCORING SYSTEM; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TASK PERFORMANCE;

EID: 0041589445     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(03)00066-0     Document Type: Article

References (17)

1. DSM-IV: Diagnostic and Statistical Manual of Mental Disorders. Fourth ed:1994;Author, Washington, DC.
2. Andrew H.G. Clinical relationship of extrapyramidal symptoms and tardive dyskinesia. Canadian Journal of Psychiatry. 39:1994;76-80.
3. Brooks D.J., Salmon E.P., Mathias C.J., Quinn N., Leenders K.L., Bannister R., Marsden C.D., Frackowiak R.S. The relationship between locomotor disability, autonomic dysfunction, and the integrity of the striatal dopaminergic system in patients with multiple system atrophy, pure autonomic failure, and Parkinson's disease: studies with positron emission tomography. Brain. 113:1990;1539-1552.
4. 2 dopamine receptor occupancy in patients treated with classical neuroleptics and clozapine: relation to extrapyramidal side effects. Archives of General Psychiatry. 49:1992;538-544.
5. Heaton R.K., Grant I., Mathews C.G. Comprehensive Norms for an Expanded Halstead-Reitan Battery: Demographic Correlations, Research Findings, and Clinical Application. 1991;Psychological Assessment Resources, Odessa, FL.
6. Holthoff V.A., Kessler J., Pietrzyk U., Bonner J., Herholz K., Wienhard K., Wagner R., Vieregge P., Heiss W.-D. Motor and cognitive deficits in Parkinson's disease are related to striatal dopamine uptake. Journal of Cerebral Blood Flow and Metabolism. 13:1993;S253.
7. 2 dopamine receptor occupancy during treatment with neuroleptic drugs. Psychiatry Research: Neuroimaging. 90:1999;31-39.
8. 2 receptors. Nuclear Medicine Communications. 19:1998;781-787.
9. Laruelle M. Imaging synaptic neurotransmission with in vivo binding competition techniques: a critical review. Journal of Cerebral Blood Flow and Metabolism. 20:2000;423-451.
10. Lieberman J.A., Mailman R. Decline of dopamine: effects of age and acute neuroleptic challenge. American Journal of Psychiatry. 155:1998;319-323.
11. McEvoy J.P., Hogarty G.E., Steingard S. Optimal dose of neuroleptic in acute schizophrenia. A controlled study of the neuroleptic threshold and higher haloperidol dose. Archives of General Psychiatry. 48:1991;739-745.
12. Owen F., Cross A.J., Crow T.J., Longden A., Poulter M., Riley G.J. Increased dopamine-receptor sensitivity in schizophrenia. Lancet. 2:1978;223-226.
13. 2-dopamine receptor occupancy differs between patients with and without extrapyramidal side effects. Acta Psychiatrica Scandinavica. 90:1994;266-268.
14. Sheehan D.V., Lecrubier Y., Sheehan K.H., Amorim P., Janavs J., Weiller E., Hergueta T., Baker R., Dunbar G.C. The Mini-International Neuropsychiatric Interview (M.I.N.I.): the development and validation of a structured diagnostic psychiatric interview for DSM-IV and ICD-10. Journal of Clinical Psychiatry. 59:1998;22-33.
15. Tedroff J., Aquilonius S.M., Hartvig P., Bredberg E., Bjurling P., Långström B. Cerebral uptake and utilization of therapeutic [beta-11C]-L-DOPA in Parkinson's disease measured by positron emission tomography. Relations to motor response. Acta Neurologica Scandinavica. 85:1992;95-102.
16. Volkow N.D., Gur R.C., Wang G.J., Fowler J.S., Moberg P.J., Ding Y.S., Hitzemann R., Smith G., Logan J. Association between decline in brain dopamine activity with age and cognitive and motor impairment in healthy individuals. American Journal of Psychiatry. 155:1998;344-349.
17. 2-like dopamine receptor density in Tourette syndrome measured by PET. Journal of Nuclear Medicine. 38:1997;1243-1247.